Abstract
BackgroundTargeting neoantigens by adoptive cell therapy (ACT) can effectively treat advanced solid tumors.1–5 However, the conventional rapid expansion protocol (REP) for T-cell expansion can stimulate bystander cells6–8 and cause differentiation...
Published Version (Free)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have